Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln
4/6 06:56
(RTTNews) - Merus N.V. (MRUS), a Dutch oncology company developing multispecific antibodies and antibody drug conjugates, Wednesday announced the pricing of an underwritten public offering of around 5.26 million shares, at a price of $57.00 per share. The gross proceeds from the...